Bausch Health Companies Inc. Uncategorized Contracts & Agreements
28 Contracts & Agreements
- Letter dated as of July 18, 2024, amending the offer letter to John Barresi, dated as of September 30, 2023 (Filed With SEC on October 31, 2024)
- Amended and Restated Employee Matters Agreement dated as of July 31, 2024, by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation (Filed With SEC on August 1, 2024)
- Offer Letter regarding Appointment of John Barresi as Interim Chief Financial Officer, dated as of September 26, 2023 (Filed With SEC on May 2, 2024)
- Form of PSU Award Agreement (Filed With SEC on May 4, 2023)
- Form of Option Grant Agreement (Filed With SEC on May 10, 2022)
- Form of RSU Grant Agreement (Filed With SEC on May 10, 2022)
- Director Nomination and Appointment Agreement by and among Bausch Health Companies Inc., Carl C. Icahn and the persons and entities listed therein, dated February 23, 2021 (Filed With SEC on February 24, 2021)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended (Filed With SEC on February 19, 2020)
- [Signature PageFollows] (Filed With SEC on March 1, 2017)
- [Signature Page Follows] (Filed With SEC on March 1, 2017)
- Page 2 of 4 (Filed With SEC on April 29, 2016)
- DEUTSCHE BANK AG NEW YORK BRANCH DEUTSCHE BANK AG CAYMAN ISLANDS BRANCH DEUTSCHE BANK SECURITIES INC. 60 Wall Street New York,NY 10005 (Filed With SEC on February 23, 2015)
- Sincerely, (Filed With SEC on February 28, 2014)
- Valeant Pharmaceuticals International, Inc. (Filed With SEC on February 28, 2014)
- GOLDMAN SACHS LENDING PARTNERS LLC GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 (Filed With SEC on May 31, 2013)
- JPMORGAN CHASE BANK, N.A. 270 Park Avenue New York, New York 10017 J.P. MORGAN SECURITIES LLC 383 Madison Avenue New York, New York 10017 (Filed With SEC on November 5, 2012)
- JPMORGAN CHASE BANK, N.A. 270 Park Avenue New York, New York 10017 J.P. MORGAN SECURITIES LLC 383 Madison Avenue New York, New York 10017 (Filed With SEC on September 4, 2012)
- DATED 29 JUNE 2011 MEDA PHARMA SARL - and - VALEANT INTERNATIONAL (BARBADOS) SRL (Filed With SEC on August 8, 2011)
- VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (Filed With SEC on March 23, 2011)
- W I T N E S S E T H : (Filed With SEC on February 28, 2011)
- VALEANT PHARMACEUTICALS INTERNATIONAL (Filed With SEC on February 9, 2011)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 27, 2010)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 27, 2010)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 14, 2010)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 14, 2010)
- VALEANT PHARMACEUTICALS INTERNATIONAL (Filed With SEC on November 26, 2010)
- By: /s/ J. Michael Pearson J. Michael Pearson Chief Executive Officer /s/ Rajiv De Silva Rajiv De Silva (Filed With SEC on November 17, 2010)
- CONFIDENTIAL TREATMENT REQUESTED: Portions of this Exhibit have been redacted pursuant to a request forconfidential treatment under Rule 24b-2 of the General Rules and... (Filed With SEC on February 26, 2010)
